Testing effectiveness (Phase 2)Ended earlyNCT02119676What this trial is testingStudy of Ruxolitinib in Colorectal Cancer PatientsWho this might be right forCRC (Colorectal Cancer) Incyte Corporation 396
Testing effectiveness (Phase 2)Study completedNCT00003276What this trial is testingIrinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerWho this might be right forGallbladder Cancer Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Study completedNCT04733768What this trial is testing18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate CancerWho this might be right forProstate Cancer University of Alberta 100
Early research (Phase 1)UnknownNCT02293850What this trial is testingPhase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Oncolys BioPharma Inc 18
Testing effectiveness (Phase 2)Study completedNCT05708950What this trial is testingA Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)Who this might be right forCancerSolid TumorMelanoma+14 more Kineta Inc. 40
Not applicableWithdrawnNCT05116618What this trial is testingDetection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearrangedWho this might be right forNon-Small Cell Lung Cancer University of Colorado, Denver
Not applicableStudy completedNCT02129218What this trial is testingLow Glycemic Load Diet in Patients With Stage I-III Colon CancerWho this might be right forStage I Colon CancerStage II Colon CancerStage III Colon Cancer+3 more Case Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07818018What this trial is testing2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction AdenocarcinomaWho this might be right forEsophageal CancerAdvanced Esophageal CancerGastric Cancer+5 more Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591597What this trial is testingA Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal CancerWho this might be right forMetastatic Colorectal NeoplasmsMicrosatellite Stable / Proficient Mismatch Repair Colorectal Cancer National Cancer Center Hospital East 68
Testing effectiveness (Phase 2)UnknownNCT03902197What this trial is testingCD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL PatientsWho this might be right forAcute Lymphoblastic Leukemia Xuanwu Hospital, Beijing 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06788197What this trial is testingSHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer PatientsWho this might be right forBreast CancerLocally Advanced or Metastatic Breast Cancer Henan Cancer Hospital 52
Not applicableStudy completedNCT04142710What this trial is testingPragmatic Randomized Control Trial of Telehealth vs Standard Care in Follow-up of Patients With Chronic ConditionsWho this might be right forChronic DiseaseDiabetesVascular Diseases+3 more University of Oslo 732
Large-scale testing (Phase 3)Study completedNCT00910910What this trial is testingStudy Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)Who this might be right forB-Cell Chronic Lymphocytic Leukemia Celgene 450
Testing effectiveness (Phase 2)Looking for participantsNCT07789210What this trial is testingA Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable MetastasesWho this might be right forColorectal CancerBRAF V600E Mutation PositiveEncorafenib+1 more Zhejiang University 25
Testing effectiveness (Phase 2)Study completedNCT00802113What this trial is testingAutologous and Allogeneic Transplant for Relapsed LymphomaWho this might be right forNon-Hodgkin's LymphomaHodgkins Disease Columbia University 30
Testing effectiveness (Phase 2)Study completedNCT00059813What this trial is testingOblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell CancerWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 41
Very early researchLooking for participantsNCT07341360What this trial is testingPseudovax - A Cancer Vaccine for Patients With Pseudomyxoma PeritoneiWho this might be right forPseudomyxoma Peritonei Oslo University Hospital 10
Not applicableStudy completedNCT04716920What this trial is testingTai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more Thomas Jefferson University 39
Post-approval studies (Phase 4)Ended earlyNCT03040024What this trial is testingDelirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) PatientsWho this might be right forOtolaryngeal Cancer Emory University 71
Not applicableLooking for participantsNCT00242723What this trial is testingEvaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung LiningWho this might be right forThoracic CancersMalignant Pleural Mesotheliomas NOSLung Cancer NOS+3 more National Cancer Institute (NCI) 1,559